Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Interventional Lung Solutions Market Through 2034?

The market size of interventional lung solutions has seen a robust growth in the past few years. The forecast for its progress is such that, it will expand from a value of $2.3 billion in 2024 to about $2.47 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The expansion during the historic period is mainly due to factors such as a rising number of lung illnesses, an increase in smokers globally, elevated levels of air pollution, enhanced health consciousness, and an increase in lung cancer diagnoses.

In the coming years, the interventional lung solutions market is projected to experience robust growth. It is predicted to escalate to $3.39 billion in 2029 with a compound annual growth rate (CAGR) of 8.2%. The expansion during the forecast period is attributable to the rising implementation of telemedicine and remote surveillance, an intensified focus on personalized medicine, growing popularity of robotically-assisted surgeries, an uptick in the adoption of minimally invasive techniques, and a rising emphasis on precision medicine. Key trends for the forecast period comprise development of lung cancer interventions, the integration of artificial intelligence into bronchoscopy systems, fusing interventional pulmonology with oncology procedures, incorporating digital platforms for lung ailment management, as well as the innovation of lung regeneration treatments.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24258&type=smp

Which Primay Drivers Are Accelerating Growth in the Interventional Lung Solutions Market?

The expansion of the interventional lung solutions market is anticipated to be spurred on by the escalating incidence of respiratory diseases. Respiratory diseases are a spectrum of health issues that impair lung and respiratory tract function, causing breathing difficulties and hindering normal respiration. The surge in such diseases can be attributed to increasing levels of air pollution, leading to constant exposure to hazardous airborne particles and irritants. Interventional lung solutions contribute to the control of such diseases by providing minimally invasive procedures that enhance lung function and mitigate symptoms in individuals suffering chronic pulmonary conditions. For instance, in 2023, the Centers for Disease Control and Prevention, a US government agency, reported that in 2022, there were approximately 8,331 reported tuberculosis cases in the United States, signifying a 5.9% increase from the previous year, 2021. Consequently, the growing incidence of respiratory diseases fuels the demand for the interventional lung solutions market.

Which Primary Segments of the Interventional Lung Solutions Market Are Driving Growth and Industry Transformations?

The interventional lung solutions market covered in this report is segmented –

1) By Product Type: Bronchoscopes, Endobronchial Ultrasound Needles, Pleuroscopes, Airway Stents, Other Product Types

2) By Technology: Robotic Surgery, Laser Therapy, Electromagnetic Navigation Bronchoscopy

3) By Procedure: Bronchoscopy, Thoracoscopy, Pleuroscopy, Other Procedures

4) By Application: Lung Cancer Treatment, Chronic Obstructive Pulmonary Disease, Sleep Apnea Treatment

5) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) BY Bronchoscopes: Flexible Bronchoscopes, Rigid Bronchoscopes, Disposable Bronchoscopes

2) By Endobronchial Ultrasound Needles: Transbronchial Aspiration Needles, Biopsy Needles

3) By Pleuroscopes: Flexible Pleuroscopes, Semi-Rigid Pleuroscopes

4) By Airway Stents: Metallic Stents, Silicone Stents, Hybrid Stents

5) By Other Product Types: Bronchial Thermoplasty Devices, Lung Volume Reduction Devices, Electromagnetic Navigation Systems, Cryotherapy And Ablation Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=24258&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Interventional Lung Solutions Market?# Market?

North America was the largest region in the interventional lung solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional lung solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Interventional Lung Solutions Industry Dynamics?

Key players in the interventional lung solutions market are prioritizing the advancement of pioneering technologies like the Ion Endoluminal System. These advancements aim to augment lung cancer diagnostic precision, facilitate less invasive methods, and boost patient results through high-tech navigation and biopsy abilities. The Ion Endoluminal System is an automation-assisted platform tailored for less invasive pulmonary procedures, permitting accurate airway guidance to touch base with tiny or difficult-to-access lung nodules. For instance, H. Lee Moffitt Cancer Center and Research Institute Foundation Inc., a non-profit organization based in the US, introduced a new Ion Robotic Bronchoscopy platform in April 2024, significantly improving their interventional pulmonology program by incorporating advanced fiber-optic technology and a minimally invasive catheter system. The device, equipped with fiber optics and the market’s smallest catheter, can access every part of the lung. The platform includes an ultra-slim, highly dextrous catheter with a 180° articulation, integrated live vision, and shape-sensing technology, guaranteeing accurate navigation and biopsy of difficult-to-reach peripheral lung nodules. The system offers unmatched stability and precision for tissue sampling, empowering physicians to access all 18 lung segments and thus enhancing early lung cancer detection.

View the full report here:

https://www.thebusinessresearchcompany.com/report/interventional-lung-solutions-global-market-report

What Parameters Are Used to Define the Interventional Lung Solutions Market?

Interventional lung solutions refer to minimally invasive procedures and technologies used to diagnose and treat lung conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, and emphysema. These solutions often include bronchoscopy interventions, endobronchial valves, and image-guided therapies that improve lung function and patient outcomes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24258

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model